How beta blockers can help prevent bone loss after menopause
Molecular and cellular mechanisms of prevention of bone loss by beta blockers
This study is looking at whether beta blockers, a common heart medication, can help prevent bone loss in women after menopause, and it aims to understand how these medications work in the body to keep bones healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mainehealth NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-10910152 on NIH RePORTER |
What this research studies
This research investigates the potential of beta blockers, a common medication, to prevent bone loss in post-menopausal women. It aims to understand the molecular and cellular mechanisms behind this effect, particularly focusing on the ADRB1 gene and its variants. By exploring how beta blockers interact with bone cells and influence bone density, the study seeks to provide insights into personalized treatment strategies. Patients may be involved in trials assessing the effectiveness and safety of these medications for improving bone health.
Who could benefit from this research
Good fit: Ideal candidates for this research are post-menopausal women who are at risk of bone loss or osteoporosis.
Not a fit: Patients who are not post-menopausal or those who do not have risk factors for bone loss may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options for preventing bone loss in post-menopausal women, potentially reducing the risk of fractures and osteoporosis.
How similar studies have performed: Previous studies have shown promising results with beta blockers in improving bone health, indicating that this approach may be effective.
Where this research is happening
Portland, United States
- Mainehealth — Portland, United States (Active)
Researchers
- Principal investigator: Motyl, Katherine Jean — Mainehealth
- Study coordinator: Motyl, Katherine Jean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.